Retraction: Modification of Cysteine Residue in p65 Subunit of Nuclear Factor-κB (NF-κB) by Picroliv Suppresses NF-κB–Regulated Gene Products and Potentiates Apoptosis

Registos relacionados

• Modification of Cysteine Residue in p65 Subunit of Nuclear Factor-κB by Picroliv Suppresses NF-κB-Regulated Gene Products and Potentiates Apoptosis
  Por: Anand, Preetha, et al.
  Publicado em: (2008)
• Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB–regulated gene products and potentiation of apoptosis in leukemia cells
  Por: Harikumar, Kuzhuvelil B., et al.
  Publicado em: (2009)
• Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB
  Por: Madrid, Lee V., et al.
  Publicado em: (2000)
• Tristetraprolin Impairs NF-κB/p65 Nuclear Translocation
  Por: Schichl, Yvonne M., et al.
  Publicado em: (2009)
• Bharangin, a Diterpenoid Quinonemethide, Abolishes Constitutive and Inducible Nuclear Factor-κB (NF-κB) Activation by Modifying p65 on Cysteine 38 Residue and Reducing Inhibitor of Nuclear Factor-κB α Kinase Activation, Leading to Suppression of NF-κB-Regulated Gene Expression and Sensitization of Tumor Cells to Chemotherapeutic Agents
  Por: Gupta, Subash C., et al.
  Publicado em: (2011)